SELLAS Life Sciences SLS
NASDAQ SLS
$11.54 +0.19 (+1.67%)
At close: Oct 23, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Cost of Revenue (2013 - 2022)

Updated

SELLAS Life Sciences' Cost of Revenue was $100,000 in FY2022, down 50.0% from $200,000 in FY2021.

Analysis

SELLAS Life Sciences (SLS) Cost of Revenue (2013 - 2022) Analysis & Trends

From FY2013 onward, SELLAS Life Sciences has reported Cost of Revenue for 4 years.

  • Per Business Quant data, Cost of Revenue in earlier years was $200,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 SELLAS Life Sciences 2.33 Bn 1.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 100,000.00
Jun 30, 2021 100,000.00
Mar 31, 2021 100,000.00
Jun 30, 2015 468,000.00
Mar 31, 2015 393,000.00
Dec 31, 2014 478,000.00
Sep 30, 2014 247,000.00
Jun 30, 2014 347,000.00
Mar 31, 2014 331,000.00
Dec 31, 2013 262,000.00
Sep 30, 2013 258,000.00
API Access

SELLAS Life Sciences Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SLS&period=max&api_key=YOUR_API_KEY